Literature DB >> 16075039

Inherited disorders of voltage-gated sodium channels.

Alfred L George1.   

Abstract

A variety of inherited human disorders affecting skeletal muscle contraction, heart rhythm, and nervous system function have been traced to mutations in genes encoding voltage-gated sodium channels. Clinical severity among these conditions ranges from mild or even latent disease to life-threatening or incapacitating conditions. The sodium channelopathies were among the first recognized ion channel diseases and continue to attract widespread clinical and scientific interest. An expanding knowledge base has substantially advanced our understanding of structure-function and genotype-phenotype relationships for voltage-gated sodium channels and provided new insights into the pathophysiological basis for common diseases such as cardiac arrhythmias and epilepsy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16075039      PMCID: PMC1180550          DOI: 10.1172/JCI25505

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  158 in total

1.  Linking a genetic defect to its cellular phenotype in a cardiac arrhythmia.

Authors:  C E Clancy; Y Rudy
Journal:  Nature       Date:  1999-08-05       Impact factor: 49.962

2.  Enhanced Na(+) channel intermediate inactivation in Brugada syndrome.

Authors:  D W Wang; N Makita; A Kitabatake; J R Balser; A L George
Journal:  Circ Res       Date:  2000-10-13       Impact factor: 17.367

3.  Multiple mechanisms of Na+ channel--linked long-QT syndrome.

Authors:  R Dumaine; Q Wang; M T Keating; H A Hartmann; P J Schwartz; A M Brown; G E Kirsch
Journal:  Circ Res       Date:  1996-05       Impact factor: 17.367

4.  A novel SCN5A mutation associated with idiopathic ventricular fibrillation without typical ECG findings of Brugada syndrome.

Authors:  J Akai; N Makita; H Sakurada; N Shirai; K Ueda; A Kitabatake; K Nakazawa; A Kimura; M Hiraoka
Journal:  FEBS Lett       Date:  2000-08-11       Impact factor: 4.124

Review 5.  Efficacy of quinidine in high-risk patients with Brugada syndrome.

Authors:  Bernard Belhassen; Aharon Glick; Sami Viskin
Journal:  Circulation       Date:  2004-09-20       Impact factor: 29.690

6.  Electrophysiological properties of mutant Nav1.7 sodium channels in a painful inherited neuropathy.

Authors:  Theodore R Cummins; Sulayman D Dib-Hajj; Stephen G Waxman
Journal:  J Neurosci       Date:  2004-09-22       Impact factor: 6.167

7.  Effectiveness of sotalol treatment in symptomatic Brugada syndrome.

Authors:  Kathryn A Glatter; Qing Wang; Mark Keating; Shenghan Chen; Nipavan Chiamvimonvat; Melvin M Scheinman
Journal:  Am J Cardiol       Date:  2004-05-15       Impact factor: 2.778

8.  Sodium channel mutations in paramyotonia congenita and hyperkalemic periodic paralysis.

Authors:  L J Ptacek; L Gouw; H Kwieciński; P McManis; J R Mendell; R J Barohn; A L George; R L Barchi; M Robertson; M F Leppert
Journal:  Ann Neurol       Date:  1993-03       Impact factor: 10.422

9.  Mutations of sodium channel alpha subunit type 1 (SCN1A) in intractable childhood epilepsies with frequent generalized tonic-clonic seizures.

Authors:  Tateki Fujiwara; Takashi Sugawara; Emi Mazaki-Miyazaki; Yukitoshi Takahashi; Katsuyuki Fukushima; Masako Watanabe; Keita Hara; Tateki Morikawa; Kazuichi Yagi; Kazuhiro Yamakawa; Yushi Inoue
Journal:  Brain       Date:  2003-03       Impact factor: 13.501

10.  Correlating phenotype and genotype in the periodic paralyses.

Authors:  T M Miller; M R Dias da Silva; H A Miller; H Kwiecinski; J R Mendell; R Tawil; P McManis; R C Griggs; C Angelini; S Servidei; J Petajan; M C Dalakas; L P W Ranum; Y H Fu; L J Ptácek
Journal:  Neurology       Date:  2004-11-09       Impact factor: 9.910

View more
  153 in total

1.  Mechanism and molecular basis for the sodium channel subtype specificity of µ-conopeptide CnIIIC.

Authors:  René Markgraf; Enrico Leipold; Jana Schirmeyer; Marianne Paolini-Bertrand; Oliver Hartley; Stefan H Heinemann
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

Review 2.  Genetic disorders of ion channels.

Authors:  Decha Enkvetchakul
Journal:  Mo Med       Date:  2010 Jul-Aug

3.  Open- and closed-state fast inactivation in sodium channels: differential effects of a site-3 anemone toxin.

Authors:  James Groome; Frank Lehmann-Horn; Boris Holzherr
Journal:  Channels (Austin)       Date:  2011-01-01       Impact factor: 2.581

4.  Transmembrane segments prevent surface expression of sodium channel Nav1.8 and promote calnexin-dependent channel degradation.

Authors:  Qian Li; Yuan-Yuan Su; Hao Wang; Lei Li; Qiong Wang; Lan Bao
Journal:  J Biol Chem       Date:  2010-08-18       Impact factor: 5.157

5.  Probing kinetic drug binding mechanism in voltage-gated sodium ion channel: open state versus inactive state blockers.

Authors:  Krishnendu Pal; Gautam Gangopadhyay
Journal:  Channels (Austin)       Date:  2015       Impact factor: 2.581

6.  Voltage-gated sodium channels are required for heart development in zebrafish.

Authors:  Sameer S Chopra; Dina Myers Stroud; Hiroshi Watanabe; Jeffrey S Bennett; C Geoffrey Burns; K Sam Wells; Tao Yang; Tao P Zhong; Dan M Roden
Journal:  Circ Res       Date:  2010-03-25       Impact factor: 17.367

Review 7.  The channelopathies: novel insights into molecular and genetic mechanisms of human disease.

Authors:  Robert S Kass
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

8.  Topochemical models for the prediction of voltage-gated sodium channel binding activity of hydantoins and related non-hydantoins.

Authors:  Meenal Gupta; Anil Kumar Madan
Journal:  J Mol Model       Date:  2006-09-07       Impact factor: 1.810

9.  (What to do) when epilepsy gene mutations stop making sense.

Authors:  Edward C Cooper
Journal:  Epilepsy Curr       Date:  2007 Jan-Feb       Impact factor: 7.500

10.  Functional modulation of voltage-dependent sodium channel expression by wild type and mutated C121W-β1 subunit.

Authors:  Debora Baroni; Raffaella Barbieri; Cristiana Picco; Oscar Moran
Journal:  J Bioenerg Biomembr       Date:  2013-04-13       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.